SCHEMBL5501667

SCHEMBL5501667

Cc1c(C(=O)O)oc2ccc(S(=O)(=O)Nc3ccccc3)cc12

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.69
ALDH1A1 P00352 4/20 0.61
HPGD P15428 7/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
HIF1A Q16665 5/20 0.57
TSHR P16473 1/20 0.56
NR1H4 Q96RI1 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
RECQL P46063 1/20 0.54
HSD17B10 Q99714 1/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
MCL1 Q07820 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8277147 0.90 GAA (0.57) GAAALDH1A1SMN1; SMN2HIF1AMEN1
SCHEMBL26603400 0.89 GAA (0.59) GAAALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL26603310 0.89 HIF1A (0.73) GAAALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL30626166 0.89 HIF1A (0.73) GAAALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL30709101 0.88 GAA (0.59) GAAALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL26603470 0.88 GAA (0.59) GAAALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL30709096 0.87 GAA (0.57) GAAALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL26603583 0.87 GAA (0.57) GAAALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL26603263 0.86 HIF1A (0.67) GAAALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL26603432 0.86 GAA (0.56) GAAALDH1A1HPGDSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776106-A1 HETEROCYCLIC DERIVATIVES FOR MODULATION OF CALCIUM CHANNELS Vertex Pharmaceuticals Incorporated (US) 2007-04-25 EP disclosed
WO-2006010008-A1 HETEROCYCLIC DERIVATIVES FOR MODULATION OF CALCIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-01-26 WO disclosed